Oscar Health, Inc. (NYSE: OSCR), a leading consumer healthcare company, today announced the appointments of Tomer Cohen, Eric Larsen, and Rajat Taneja to its Board of Directors, effective November 13, 2026.

“Oscar Health is leading the next generation of consumer healthcare,” said Mark Bertolini, CEO of Oscar Health. “We are growing the ACA into a larger individual market with superior lifestyle products and differentiated technology platforms that make the healthcare experience affordable and easy to navigate. We are excited to welcome Tomer, Eric, and Rajat as we scale Oscar Health and build a new consumer marketplace that sets the standard for healthcare innovation everywhere.”

Mr. Cohen is a technology and product leader with a track record of growing consumer-focused startups and established companies. He served as LinkedIn Corporation’s Senior Vice President and Chief Product Officer from 2020 to 2026, and subsequently as an Executive Advisor. In his role as Senior Vice President and Chief Product Officer, Mr. Cohen set the company’s product strategy, oversaw product development, user experience design, business development, content creation, and customer operations, and advanced AI across the organization. He also served in various key leadership roles at LinkedIn from 2012 to 2020, helping launch and scale new innovative member experiences. Prior to LinkedIn, Mr. Cohen worked as an entrepreneur with Greylock Partners and founded a company in the personal CRM space. He teaches AI for product and business leaders at Stanford Graduate School of Business and serves on the board of Gusto. Mr. Cohen holds a B.S. from Ben-Gurion University of the Negev and an M.B.A. from Stanford University.

Mr. Larsen brings decades of leadership across healthcare, private equity, and venture capital, with a forward-looking perspective on frontier AI. He serves as President of TowerBrook Advisors and as a member of TowerBrook Capital Partners healthcare leadership team, having held these roles since 2023. Mr. Larsen previously served as President of The Advisory Board Company, L.P. from 2019 to 2023 and subsequently as President Emeritus. He is also a senior advisor to Thrive Capital, Oscar Health’s majority stockholder, and serves on the boards of R1 RCM, eMed Population Health, Thrive Global, and as Chairman of the Washington National Opera. Mr. Larsen holds a B.S. in Foreign Service from Georgetown University.

Mr. Taneja is a seasoned technology executive with extensive experience building secure technology platforms at global scale. He has served as President of Technology at Visa, Inc., leading global technology research, product development, cybersecurity, operations and infrastructure, and technology innovation and investment strategy since 2019. Mr. Taneja was previously Executive Vice President of Technology and Operations at Visa from 2013 to 2019, Executive Vice President and Chief Technology Officer of Electronic Arts, Inc. from 2011 to 2013, and held senior leadership roles at Microsoft Corporation. He serves on the board of MSCI Inc., where he chairs the Technology and Data Committee and serves on the Audit and Risk Committee. Mr. Taneja holds a B.E. from Jadavpur University and an M.B.A. from Washington State University.

“Tomer, Eric, and Rajat bring exceptional expertise across consumer products, healthcare, and technology with a shared commitment to innovation,” said Sid Sankaran, Chairman of Oscar Health’s Board of Directors. “Their complementary experience and fresh perspectives will strengthen our Board as Oscar Health builds on its technology foundation, creates better experiences for consumers, and pursues its next phase of growth.”

About Oscar Health

Oscar Health, Inc. (NYSE: OSCR) is a leading consumer health company that gives people power over their healthcare. Oscar Health serves millions of consumers, employers, brokers, and partners through Oscar Insurance, Lucie Health Marketplace, and Trove Group. Together these businesses deliver exceptional lifestyle products and technology platforms that make healthcare easy to choose, use, and experience. Learn more at OscarHealth.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements about our business and financial prospects, including management’s plans and objectives for future operations, expectations and business strategy, and industry and market dynamics and expected trends. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond our control. Although management believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, there are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the factors set forth under the caption “Risk Factors” in our in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”), and our other filings with the SEC. You are cautioned not to place undue reliance on any forward-looking statements made in this press release. Any forward-looking statement speaks only as of the date as of which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise.

Media gallery

About The Author